Skip to main content
Year archive

Pharming Group N.V. — 2010 filings

All 52 regulatory filings released by Pharming Group N.V. (PHARM) in 2010, sourced directly from the official regulator.

52 Filings
2010 Period
2010 filings (52)
Filing Released Lang
Pharming and Santarus announce submission of Rhucin Biologics License Application to FDA
Regulatory Filings
2010-12-28 English
Pharming and Swedish Orphan Biovitrum announce first sales of Ruconest in Europe
Regulatory Filings
2010-12-28 English
SOCIUS EXERCISES INVESTMENT RIGHTS
Capital/Financing Update
2010-12-06 English
PHARMING ANNOUNCES EURO 16.1 MILLION INVESTMENT FROM SOCIUS CAPITAL GROUP
Capital/Financing Update
2010-12-03 English
PHARMING AWARDED ‘BEST BIOTECHNOLOGY COMPANY’ BY THE WORLD TECHNOLOGY NETWORK
Regulatory Filings
2010-12-02 English
PHARMING AWARDED ‘BEST BIOTECHNOLOGY COMPANY’ BY THE WORLD TECHNOLOGY NETWORK
Regulatory Filings
2010-12-02 English
PHARMING ANNOUNCES TOPLINE STUDY RESULTS ON PROPHYLACTIC USE OF RUCONEST IN HEREDITARY ANGIOEDEMA
Regulatory Filings
2010-11-29 English
PHARMING ANNOUNCES TOPLINE STUDY RESULTS ON PROPHYLACTIC USE OF RUCONEST IN HEREDITARY ANGIOEDEMA
Regulatory Filings
2010-11-29 English
Pharming's Ruconest For Hae Granted European Marketing Authorization
Regulatory Filings
2010-10-29 English
Pharming announces nine month financial report 2010
Interim / Quarterly Report 9M 2010
2010-10-21 English
Interim / Quarterly Report 2010
Interim / Quarterly Report 9M 2010
2010-10-21 English
Pharming confirms anticipated call from public bondholders to exercise put option
Capital/Financing Update
2010-10-12 English
PHARMING AND SWEDISH ORPHAN ANNOUNCE PUBLICATION OF RANDOMIZED CLINICAL TRIAL RESULTS WITH PHARMING’S RECOMBINANT HUMAN C1 INHIBITOR
Regulatory Filings
2010-10-05 Swedish
Pharming shareholders appoint Karl Keegan as CFO
Share Issue/Capital Change
2010-10-01 English
Pharming signs commercialization agreement with Santarus for Rhucin® in North America
Regulatory Filings
2010-09-13 English
Pharming clears 2010 private bond debt
Capital/Financing Update
2010-09-02 English
Pharming plans submission Rhucin BLA to US FDA end 2010
Regulatory Filings
2010-08-25 English
Pharming provides update on outstanding shares
Share Issue/Capital Change
2010-08-25 English
Pharming's Supervisory Board Nominates CFO
Board/Management Information
2010-08-19 English
PHARMING PROVIDES UPDATE ON OUTSTANDING SHARES
Share Issue/Capital Change
2010-08-18 English
Pharming provides update on outstanding shares
Share Issue/Capital Change
2010-08-06 English
Pharming publishes financial report first half year 2010
Interim / Quarterly Report H1 2010
2010-07-21 English
Interim / Quarterly Report 2010
Interim / Quarterly Report H1 2010
2010-07-21 English
Pharming completes spin-off of DNage
M&A Activity
2010-07-19 English
Pharming provides update on outstanding shares
Share Issue/Capital Change
2010-07-12 English
Pharming and Sanofi Chimie sign manufacturing agreement for the drug substance of Ruconest
Regulatory Filings
2010-07-06 English
Pharming provides update on outstanding shares
Share Issue/Capital Change
2010-06-30 English
Pharming receives positive opinion from European Medicines Agency on Rhucin
Earnings Release Q2 2010
2010-06-24 English
Pharming provides update on outstanding shares
Share Issue/Capital Change
2010-06-21 English
Pharming provides background information on recently completed private offering
Share Issue/Capital Change
2010-06-15 English
PHARMING PROVIDES UPDATE ON OUTSTANDING SHARES
Share Issue/Capital Change
2010-06-03 English
Pharming reports On Shareholders Meeting
AGM Information
2010-06-02 English
PHARMING SUCCESSFULLY COMPLETES EQUITY FUNDRAISING OF €12 MILLION
Share Issue/Capital Change
2010-05-28 English
PHARMING LAUNCHES EQUITY OFFERING OF UP TO €12 MILLION - Initial commitments of €5.5 million confirmed
Share Issue/Capital Change
2010-05-28 English
PHARMING INITIATES EQUITY FUNDRAISING
Share Issue/Capital Change
2010-05-27 English
PHARMING SUBMITS D180 RESPONSE FOR RHUCIN MAA TO EMA WITHOUT CLOCK STOP - Final opinion now expected by end of June
Legal Proceedings Report
2010-05-25 English
PHARMING RECEIVES D180 LIST OF OUTSTANDING ISSUES ON RHUCIN MAA
Regulatory Filings
2010-05-21 English
PHARMING INITIATES DIVESTMENT OF DNAGE
M&A Activity
2010-05-17 English
Pharming provides update on outstanding shares
Share Issue/Capital Change
2010-05-17 English
Annual Report 2009
Annual Report FY 2009
2010-04-30 English
Pharming publishes first quarter 2010 financial report
Interim / Quarterly Report Q1 2010
2010-04-22 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Q1 2010
2010-04-22 English
Swedish Orphan Biovitrum and Pharming sign Rhucin® distribution agreement
Regulatory Filings
2010-04-15 English
Pharming's C1 inhibitor effective in preventing AMR in animal model of transplant rejection
Regulatory Filings
2010-04-01 English
Pharming shareholders approve items on EGM agenda
AGM Information
2010-03-30 English
Pharming submits response to questions MAA Rhucin
Legal Proceedings Report
2010-03-18 English
Pharming to hold extraordinary shareholders' meeting
Share Issue/Capital Change
2010-03-15 English
Pharming announces 2009 results
Earnings Release FY 2009
2010-02-18 English
Pharming's C1 inhibitor product potentially effective in reducing complications following transplantation
Regulatory Filings
2010-02-17 English
Pharming gives update on Rhucin EU Marketing Authorization Application
Regulatory Filings
2010-01-22 English
Pharming provides business update
Earnings Release FY 2009
2010-01-12 English
Pharming obtains EURO 7.5 million financing
Capital/Financing Update
2010-01-05 English